Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis

被引:2
|
作者
Sato, Y [1 ]
Kobayashi, T [1 ]
Nakatsuka, H [1 ]
Yamamoto, S [1 ]
Oya, H [1 ]
Watanabe, T [1 ]
Hatakeyama, K [1 ]
机构
[1] Niigata Univ, Sch Med, Dept Surg 1, Niigata 9518510, Japan
关键词
shear stress; portal hypertension; portal pressure; liver regeneration; liver injury;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: In this study, we investigated whether a reduction of surplus portal hypertension after a major hepatectomy by SPL (splenic arterial ligation) prevents a liver injury in cirrhotic patients with hepatocellular carcinoma. Methodology: Six hepatocellular carcinoma patients (SPL group) with liver cirrhosis (67 +/- 10 years old, ICGR(15): 21.0 +/-9.8%, T.Bil: 1.1 +/-1.2mg/dL) underwent major hepatectomy with splenic arterial ligation in order to reduce excessive portal hypertension after hepatectomy from 1998 to 2000, July. The patients (n=15, 60 +/-9 years old, ICGR(15): 11.5 +/-5.9%, T.Bil: 0.66 +/-0.15mg/dL) who underwent liver resection above subsegmentectomy in the same period (control group) served as the control for SPL group. Results: In the SPL group, the portal pressures before hepatectomy were 26 +/- 7cm H2O and those after hepatectomy were 29 +/- 6cm H2O. The portal pressure after splenic arterial ligation decreased to 24.5 +/-6.3cm H2O. The splenic tissue blood flows before SPL were 16.8 +/-5.6mL/min/100g, while those after SPL were 7.2 +/-2.2mL/min/100g. The portal pressures before hepatectomy were 17 +/- 2cm H2O and those after hepatectomy were 19 +/- 2cm H2O in the six control patients. At the peak levels of liver function after surgery, T.Bil was 2.6 +/-1.5mg/dL, GOT was 165 +/- 59 IU/L, and GPT was 107 +/- 49 IU/L. Ah patients could discharge without complications except for one case with bile leakage in SPL. At the peak levels of liver function in control group, T.Bil was 3.7 +/-1.9mg/dL, GOT was 404+/227 IU/L, and GPT was 322 +/- 171 IU/L. At the peak levels of Liver function after surgery, T.Bil was 3.4 +/-1.3mg/dL, GOT was 398 +/- 289 IU/L, and GPT was 319 +/- 220 IU/L. Conversely, there were 11 episodes of complications (11/15), including two cases of hospital death resulting from liver failure in patients who underwent right lobectomy, in the control patients. Conclusions: The decompression of surplus portal hypertension by SPL might be effective in the prevention of post hepatectomized Liver injury and the improvement of postoperative mortality and morbidity.
引用
收藏
页码:831 / 835
页数:5
相关论文
共 50 条
  • [31] Sequential Transcatheter Arterial Chemoembolization and Portal Vein Embolization versus Portal Vein Embolization Only before Major Hepatectomy for Patients with Hepatocellular Carcinoma
    Hyunkyung Yoo
    Jin Hyoung Kim
    Gi-Young Ko
    Kyoung Won Kim
    Dong Il Gwon
    Sung-Gyu Lee
    Shin Hwang
    Annals of Surgical Oncology, 2011, 18 : 1251 - 1257
  • [32] Sequential Transcatheter Arterial Chemoembolization and Portal Vein Embolization versus Portal Vein Embolization Only before Major Hepatectomy for Patients with Hepatocellular Carcinoma
    Yoo, Hyunkyung
    Kim, Jin Hyoung
    Ko, Gi-Young
    Kim, Kyoung Won
    Gwon, Dong Il
    Lee, Sung-Gyu
    Hwang, Shin
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (05) : 1251 - 1257
  • [33] A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension
    Ye, Jia-zhou
    Lu, Hua-ze
    Zeng, Can
    Lei, Guo
    Wang, Xiao-bo
    Chen, Jie
    Bai, Tao
    Wu, Fei-xiang
    Mai, Rong-yun
    Guo, Wei-xing
    Li, Le-qun
    BMC CANCER, 2024, 24 (01)
  • [34] Effects of terlipressin and somatostatin on liver function after major hepatectomy for hepatocellular carcinoma
    Ye, Jiangwei
    Liu, Zhikun
    Xu, Xiao
    ASIAN JOURNAL OF SURGERY, 2021, 44 (07) : 1016 - 1018
  • [35] Histologic severity of liver cirrhosis: A key factor affecting surgical outcomes of hepatocellular carcinoma in patients with portal hypertension
    Dong, Ke-shuai
    Liang, Bin-yong
    Zhang, Zun-yi
    Zhang, Er-lei
    Yang, Guang
    Xia, Shu-li
    Chen, Xiao-ping
    Huang, Zhi-yong
    ASIAN JOURNAL OF SURGERY, 2019, 42 (12) : 981 - 989
  • [36] Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction
    Kaibori, Masaki
    Tanigawa, Noboru
    Matsui, Yoichi
    Saito, Takamichi
    Uchida, Yoichiro
    Ishizaki, Morihiko
    Tanaka, Hironori
    Kamiyama, Yasuo
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3685 - 3692
  • [37] Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced hepatocellular carcinoma with macrovascular invasion
    Giammauro Berardi
    Nicola Guglielmo
    Marco Colasanti
    Roberto Luca Meniconi
    Stefano Ferretti
    Germano Mariano
    Sofia Usai
    Marco Angrisani
    Alessandra Pecoraro
    Alessio Lucarini
    Camilla Gasparoli
    Giuseppe Maria Ettorre
    Updates in Surgery, 2022, 74 : 927 - 936
  • [38] Monosegment associating liver partition and portal vein ligation for staged hepatectomy : Preserving segment 1 as the only liver remnant after hepatocellular carcinoma recurrence
    Ruiz, Eloy
    Fernandez-Placencia, Ramiro
    Bustamante, Jorge
    Medina-Cana, Jose
    Loja, Elmer
    Berrospi, Francisco
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2021, 25 (04) : 562 - 565
  • [39] Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced hepatocellular carcinoma with macrovascular invasion
    Berardi, Giammauro
    Guglielmo, Nicola
    Colasanti, Marco
    Meniconi, Roberto Luca
    Ferretti, Stefano
    Mariano, Germano
    Usai, Sofia
    Angrisani, Marco
    Pecoraro, Alessandra
    Lucarini, Alessio
    Gasparoli, Camilla
    Ettorre, Giuseppe Maria
    UPDATES IN SURGERY, 2022, 74 (03) : 927 - 936
  • [40] Minimally invasive liver surgery for hepatocellular carcinoma in patients with portal hypertension
    Aliseda, Daniel
    Zozaya, Gabriel
    Marti-Cruchanga, Pablo
    Lujan, Juan
    Almeida, Ana
    Blanco, Nuira
    Sabatella, Lucas
    Sangro, Bruno
    Rotellar, Fernando
    BJS OPEN, 2023, 7 (02):